MEDICAL
NEWS
PART
CUT
HERE
VOLUME
NUMBER
APRIL
HEALTH
INFOCOM
NETWORK
MEDICAL
NEWSLETTER
EDITOR
DAVID
DODELL
DMD
NORTH
STREET
SUITE
SCOTTSDALE
ARIZONA
USA
TELEPHONE
FAX
COMPILATION
COPYRIGHT
BY
DAVID
DODELL
DMD
ALL
RIGHTS
RESERVED
LICENSE
IS
HEREBY
GRANTED
TO
REPUBLISH
ON
ELECTRONIC
MEDIA
FOR
WHICH
NO
FEES
ARE
CHARGED
SO
LONG
AS
THE
TEXT
OF
THIS
COPYRIGHT
NOTICE
AND
LICENSE
ARE
ATTACHED
INTACT
TO
ANY
AND
ALL
REPUBLISHED
PORTION
OR
PORTIONS
THE
HEALTH
INFOCOM
NETWORK
NEWSLETTER
IS
DISTRIBUTED
BIWEEKLY
ARTICLES
ON
A
MEDICAL
NATURE
ARE
WELCOMED
IF
YOU
HAVE
AN
ARTICLE
PLEASE
CONTACT
THE
EDITOR
FOR
INFORMATION
ON
HOW
TO
SUBMIT
IT
IF
YOU
ARE
INTERESTED
IN
JOINING
THE
AUTOMATED
DISTRIBUTION
SYSTEM
PLEASE
CONTACT
THE
EDITOR
EMAIL
ADDRESS
EDITOR
INTERNET
DAVIDSTATCOM
FIDONET
BITNET
LISTSERV
MEDNEWSASUACADBITNET
OR
INTERNET
MEDNEWSASUVMINREASUEDU
ANONYMOUS
FTP
NOTIFICATION
LIST
HICNNOTIFYREQUESTSTATCOM
FAX
DELIVERY
CONTACT
EDITOR
FOR
INFORMATION
T
A
B
L
E
O
F
C
O
N
T
E
N
T
S
CENTERS
FOR
DISEASE
CONTROL
AND
PREVENTION
MMWR
APRIL
RATES
OF
CESAREAN
DELIVERY
MALARIA
AMONG
US
EMBASSY
PERSONNEL
FDA
APPROVAL
OF
HIB
VACCINE
FOR
CHILDRENINFANTS
DENTAL
NEWS
WORKSHOP
EXPLORES
ORAL
MANIFESTATIONS
OF
HIV
INFECTION
FOOD
DRUG
ADMINISTRATION
NEWS
FDA
APPROVES
DEPO
PROVERA
INJECTABLE
CONTRACEPTIVE
NEW
RULES
SPEED
APPROVAL
OF
DRUGS
FOR
LIFETHREATENING
ILLNESSES
ARTICLES
RESEARCH
PROMISES
PREVENTINGSLOWING
BLINDNESS
FROM
RETINAL
DISEASE
AFFLUENT
DIET
INCREASES
RISK
OF
HEART
DISEASE
GENERAL
ANNOUNCMENTS
PUBLICATIONS
FOR
HEALTH
PROFESSIONALS
FROM
NATIONAL
CANCER
INSTITUTE
PUBLICATIONS
FOR
PATIENTS
AVAILABLE
FROM
NATIONAL
CANCER
INSTITUTE
AIDS
NEWS
SUMMARIES
AIDS
DAILY
SUMMARY
FOR
APRIL
TO
APRIL
AIDS
STATISTICS
WORLDWIDE
AIDS
STATISTICS
HICNET
MEDICAL
NEWSLETTER
PAGE
I
VOLUME
NUMBER
APRIL
CENTERS
FOR
DISEASE
CONTROL
AND
PREVENTION
MMWR
RATES
OF
CESAREAN
DELIVERY
UNITED
STATES
SOURCE
MMWR
DATE
APR
CESAREAN
DELIVERIES
HAVE
ACCOUNTED
FOR
NEARLY
MILLION
OF
THE
APPROXIMATELY
MILLION
ANNUAL
DELIVERIES
IN
THE
UNITED
STATES
SINCE
TABLE
THE
CESAREAN
RATE
IN
THE
UNITED
STATES
IS
THE
THIRD
HIGHEST
AMONG
REPORTING
COUNTRIES
EXCEEDED
ONLY
BY
BRAZIL
AND
PUERTO
RICO
THIS
REPORT
PRESENTS
DATA
ON
CESAREAN
DELIVERIES
FROM
CDCS
NATIONAL
HOSPITAL
DISCHARGE
SURVEY
NHDS
FOR
AND
COMPARES
THESE
DATA
WITH
PREVIOUS
YEARS
DATA
ON
DISCHARGES
FROM
SHORTSTAY
NONFEDERAL
HOSPITALS
HAVE
BEEN
COLLECTED
ANNUALLY
SINCE
IN
THE
NHDS
CONDUCTED
BY
CDCS
NATIONAL
CENTER
FOR
HEALTH
STATISTICS
FOR
MEDICAL
AND
DEMOGRAPHIC
INFORMATION
WERE
ABSTRACTED
FROM
A
SAMPLE
OF
INPATIENTS
DISCHARGED
FROM
PARTICIPATING
HOSPITALS
THE
CESAREANS
AND
VAGINAL
BIRTHS
AFTER
A
PRIOR
CESAREAN
VBAC
PRESENTED
IN
THIS
REPORT
ARE
BASED
ON
WEIGHTED
NATIONAL
ESTIMATES
FROM
THE
NHDS
SAMPLE
OF
APPROXIMATELY
WOMEN
DISCHARGED
AFTER
DELIVERY
THE
ESTIMATED
NUMBERS
OF
LIVE
BIRTHS
BY
TYPE
OF
DELIVERY
WERE
CALCULATED
BY
APPLYING
CESAREAN
RATES
FROM
THE
NHDS
TO
LIVE
BIRTHS
FROM
NATIONAL
VITAL
REGISTRATION
DATA
THEREFORE
ESTIMATES
OF
THE
NUMBER
OF
CESAREANS
IN
THIS
REPORT
WILL
NOT
AGREE
WITH
PREVIOUSLY
PUBLISHED
DATA
BASED
SOLELY
ON
THE
NHDS
STATED
DIFFERENCES
IN
THIS
ANALYSIS
ARE
SIGNIFICANT
AT
THE
CONFIDENCE
LEVEL
BASED
ON
THE
TWOTAILED
TTEST
WITH
A
CRITICAL
VALUE
OF
IN
THERE
WERE
CESAREANS
PER
DELIVERIES
THE
SAME
RATE
AS
IN
AND
SIMILAR
TO
RATES
DURING
TABLE
THE
PRIMARY
CESAREAN
RATE
IE
NUMBER
OF
FIRST
CESAREANS
PER
DELIVERIES
TO
WOMEN
WHO
HAD
NO
PREVIOUS
CESAREANS
FOR
ALSO
WAS
STABLE
RANGING
FROM
TO
IN
THE
CESAREAN
RATE
IN
THE
SOUTH
WAS
SIGNIFICANTLY
HIGHER
THAN
THE
RATES
FOR
THE
WEST
MIDWEST
AND
NORTHEAST
RATES
WERE
HIGHER
FOR
MOTHERS
AGED
GREATER
THAN
OR
EQUAL
TO
YEARS
THAN
FOR
YOUNGER
WOMEN
IN
PROPRIETARY
HOSPITALS
THAN
IN
NONPROFIT
OR
GOVERNMENT
HOSPITALS
IN
HOSPITALS
WITH
FEWER
THAN
BEDS
THAN
IN
LARGER
HOSPITALS
AND
FOR
DELIVERIES
FOR
WHICH
BLUE
CROSSBLUE
SHIELD
AND
OTHER
PRIVATE
INSURANCE
IS
THE
EXPECTED
SOURCE
OF
PAYMENT
THAN
FOR
OTHER
SOURCES
OF
PAYMENT
TABLE
THE
SAME
PATTERN
CHARACTERIZED
PRIMARY
CESAREAN
DELIVERIES
SINCE
THE
EARLY
THE
NUMBER
AND
PERCENTAGE
OF
BIRTHS
TO
OLDER
WOMEN
INCREASED
HOWEVER
IF
THE
AGE
DISTRIBUTION
OF
MOTHERS
IN
HAD
REMAINED
THE
SAME
AS
IN
THE
OVERALL
CESAREAN
RATE
IN
WOULD
HAVE
BEEN
ESSENTIALLY
THE
SAME
AS
THE
OBSERVED
BASED
ON
THE
NHDS
OF
THE
APPROXIMATELY
LIVE
BIRTHS
IN
AN
HICNET
MEDICAL
NEWSLETTER
PAGE
VOLUME
NUMBER
APRIL
ESTIMATED
WERE
BY
CESAREAN
DELIVERY
OF
THESE
AN
ESTIMATED
BIRTHS
WERE
REPEAT
CESAREANS
AND
WERE
PRIMARY
CESAREANS
SINCE
APPROXIMATELY
PRIMARY
CESAREANS
HAVE
BEEN
PERFORMED
ANNUALLY
IN
OF
WOMEN
WHO
HAD
A
PREVIOUS
CESAREAN
DELIVERED
VAGINALLY
COMPARED
WITH
IN
OF
ALL
CESAREANS
IN
WERE
ASSOCIATED
WITH
A
PREVIOUS
CESAREAN
WITH
DYSTOCIA
IE
FAILURE
OF
LABOR
TO
PROGRESS
WITH
BREECH
PRESENTATION
WITH
FETAL
DISTRESS
AND
WITH
ALL
OTHER
SPECIFIED
COMPLICATIONS
THE
AVERAGE
HOSPITAL
STAY
FOR
ALL
DELIVERIES
IN
WAS
DAYS
IN
COMPARISON
THE
HOSPITAL
STAY
FOR
A
PRIMARY
CESAREAN
DELIVERY
WAS
DAYS
AND
FOR
A
REPEAT
CESAREAN
DAYS
NEARLY
TWICE
THE
DURATION
FOR
VBAC
DELIVERIES
DAYS
OR
FOR
VAGINAL
DELIVERIES
THAT
WERE
NOT
VBACS
DAYS
IN
THE
AVERAGE
HOSPITAL
STAY
FOR
ALL
DELIVERIES
WAS
DAYS
FOR
PRIMARY
CESAREANS
DAYS
FOR
REPEAT
CESAREANS
DAYS
AND
FOR
VBAC
AND
NONVBAC
VAGINAL
DELIVERIES
AND
DAYS
RESPECTIVELY
REPORTED
BY
OFFICE
OF
VITAL
AND
HEALTH
STATISTICS
SYSTEMS
NATIONAL
CENTER
FOR
HEALTH
STATISTICS
CDC
EDITORIAL
NOTE
THE
CESAREAN
RATE
IN
THE
UNITED
STATES
STEADILY
INCREASED
FROM
THROUGH
HOWEVER
THE
FINDINGS
IN
THIS
REPORT
INDICATE
THAT
RATES
HAVE
BEEN
STABLE
SINCE
BECAUSE
THERE
IS
LITTLE
EVIDENCE
THAT
MATERNAL
AND
CHILD
HEALTH
STATUS
HAS
IMPROVED
DURING
THIS
TIME
AND
BECAUSE
CESAREANS
ARE
ASSOCIATED
WITH
AN
INCREASED
RISK
FOR
COMPLICATIONS
OF
CHILDBIRTH
A
NATIONAL
HEALTH
OBJECTIVE
FOR
THE
YEAR
IS
TO
REDUCE
THE
OVERALL
CESAREAN
RATE
TO
OR
FEWER
PER
DELIVERIES
AND
THE
PRIMARY
CESAREAN
RATE
TO
OR
FEWER
PER
DELIVERIES
OBJECTIVE
POSTPARTUM
COMPLICATIONS
INCLUDING
URINARY
TRACT
AND
WOUND
INFECTIONS
MAY
ACCOUNT
IN
PART
FOR
THE
LONGER
HOSPITAL
STAYS
FOR
CESAREAN
DELIVERIES
THAN
FOR
VAGINAL
BIRTHS
MOREOVER
THE
PROLONGED
HOSPITAL
STAYS
FOR
CESAREAN
DELIVERIES
SUBSTANTIALLY
INCREASE
HEALTHCARE
COSTS
FOR
EXAMPLE
IN
THE
AVERAGE
COSTS
FOR
CESAREAN
AND
VAGINAL
DELIVERIES
WERE
AND
RESPECTIVELY
THE
ADDITIONAL
COST
FOR
EACH
CESAREAN
DELIVERY
INCLUDES
FOR
PHYSICIAN
FEES
AND
FOR
HOSPITAL
CHARGES
IF
THE
CESAREAN
RATE
IN
HAD
BEEN
THE
YEAR
OBJECTIVE
INSTEAD
OF
THE
NUMBER
OF
CESAREAN
BIRTHS
WOULD
HAVE
DECREASED
BY
VERSUS
RESULTING
IN
A
SAVINGS
OF
MORE
THAN
BILLION
IN
PHYSICIAN
FEES
AND
HOSPITAL
CHARGES
DESPITE
THE
STEADY
INCREASE
IN
VBAC
RATES
SINCE
SEVERAL
FACTORS
MAY
IMPEDE
PROGRESS
TOWARD
THE
YEAR
NATIONAL
HEALTH
OBJECTIVES
FOR
CESAREAN
DELIVERY
FOR
EXAMPLE
VBAC
RATES
SUBSTANTIALLY
REFLECT
THE
NUMBER
OF
WOMEN
OFFERED
TRIAL
OF
LABOR
WHICH
HAS
BEEN
INCREASINGLY
ENCOURAGED
SINCE
OF
WOMEN
WHO
ARE
OFFERED
A
TRIAL
OF
LABOR
COULD
DELIVER
VAGINALLY
A
LEVEL
ALREADY
ACHIEVED
BY
MANY
HOSPITALS
TRIAL
OF
LABOR
WAS
ROUTINELY
OFFERED
IN
OF
HOSPITALS
SURVEYED
IN
THE
MOST
RECENT
YEAR
FOR
WHICH
HICNET
MEDICAL
NEWSLETTER
PAGE
VOLUME
NUMBER
APRIL
NATIONAL
DATA
ARE
AVAILABLE
WHEN
THE
VBAC
RATE
ACCORDING
TO
NHDS
DATA
WAS
THE
YEAR
OBJECTIVE
SPECIFIES
A
VBAC
RATE
OF
BASED
ON
ALL
WOMEN
WHO
HAD
A
PRIOR
CESAREAN
REGARDLESS
OF
WHETHER
A
TRIAL
OF
LABOR
WAS
ATTEMPTED
TO
REACH
THE
OVERALL
CESAREAN
RATE
GOAL
HOWEVER
INCREASES
IN
THE
VBAC
RATE
WILL
NEED
TO
BE
COMBINED
WITH
A
SUBSTANTIAL
REDUCTION
IN
THE
PRIMARY
RATE
ONE
HOSPITAL
SUCCEEDED
IN
REDUCING
THE
RATE
OF
CESAREAN
DELIVERY
BY
APPLYING
OBJECTIVE
CRITERIA
FOR
THE
FOUR
MOST
COMMON
INDICATIONS
FOR
CESAREAN
DELIVERY
BY
REQUIRING
A
SECOND
OPINION
AND
BY
INSTITUTING
A
PEERREVIEW
PROCESS
OTHER
RECOMMENDATIONS
FOR
DECREASING
CESAREAN
DELIVERY
RATES
INCLUDE
ELIMINATING
INCENTIVES
FOR
PHYSICIANS
AND
HOSPITALS
BY
EQUALIZING
REIMBURSEMENT
FOR
VAGINAL
AND
CESAREAN
DELIVERIES
PUBLIC
DISSEMINATION
OF
PHYSICIAN
AND
HOSPITALSPECIFIC
CESAREAN
DELIVERY
RATES
TO
INCREASE
PUBLIC
AWARENESS
OF
DIFFERENCES
IN
PRACTICES
AND
ADDRESSING
MALPRACTICE
CONCERNS
WHICH
MAY
BE
AN
IMPORTANT
FACTOR
IN
MAINTAINING
THE
HIGH
RATES
OF
CESAREAN
DELIVERY
REFERENCES
NOTZON
FC
INTERNATIONAL
DIFFERENCES
IN
THE
USE
OF
OBSTETRIC
INTERVENTIONS
JAMA
GRAVES
EJ
NCHS
SUMMARY
NATIONAL
HOSPITAL
DISCHARGE
SURVEY
HYATTSVILLE
MARYLAND
US
DEPARTMENT
OF
HEALTH
AND
HUMAN
SERVICES
PUBLIC
HEALTH
SERVICE
CDC
ADVANCE
DATA
NO
TAFFEL
SM
PLACEK
PJ
KOSARY
CL
US
CESAREAN
SECTION
RATES
AN
UPDATE
BIRTH
PUBLIC
HEALTH
SERVICE
HEALTHY
PEOPLE
NATIONAL
HEALTH
PROMOTION
AND
DISEASE
PREVENTION
OBJECTIVES
FULL
REPORT
WITH
COMMENTARY
WASHINGTON
DC
US
DEPARTMENT
OF
HEALTH
AND
HUMAN
SERVICES
PUBLIC
HEALTH
SERVICE
DHHS
PUBLICATION
NO
DANFORTH
DN
CESAREAN
SECTION
JAMA
HOSPITAL
INSURANCE
ASSOCIATION
OF
AMERICA
TABLE
COST
OF
MATERNITY
CARE
PHYSICIANS
FEES
AND
HOSPITAL
CHARGES
BY
CENSUS
REGION
BASED
ON
CONSUMER
PRICE
INDEX
IN
SOURCE
BOOK
OF
HEALTH
INSURANCE
DATA
WASHINGTON
DC
HOSPITAL
INSURANCE
ASSOCIATION
OF
AMERICA
COMMITTEE
ON
OBSTETRICS
ACOG
COMMITTEE
OPINION
NO
GUIDELINES
FOR
VAGINAL
DELIVERY
AFTER
A
PREVIOUS
CESAREAN
BIRTH
WASHINGTON
DC
AMERICAN
COLLEGE
OF
OBSTETRICIANS
AND
GYNECOLOGISTS
HICNET
MEDICAL
NEWSLETTER
PAGE
VOLUME
NUMBER
APRIL
ROSEN
MG
DICKINSON
JC
VAGINAL
BIRTH
AFTER
CESAREAN
A
METAANALYSIS
OF
INDICATORS
FOR
SUCCESS
OBSTET
GYNECOL
SHIONO
PH
FIELDEN
JG
MCNELLIS
D
RHOADS
GG
PEARSE
WH
RECENT
TRENDS
IN
CESAREAN
BIRTH
AND
TRIAL
OF
LABOR
RATES
IN
THE
UNITED
STATES
JAMA
MYERS
SA
GLEICHER
N
A
SUCCESSFUL
PROGRAM
TO
LOWER
CESAREANSECTION
RATES
N
ENGL
J
MED
USE
OF
TRADE
NAMES
AND
COMMERCIAL
SOURCES
IS
FOR
IDENTIFICATION
ONLY
AND
DOES
NOT
IMPLY
ENDORSEMENT
BY
THE
PUBLIC
HEALTH
SERVICE
OR
THE
US
DEPARTMENT
OF
HEALTH
AND
HUMAN
SERVICES
HICNET
MEDICAL
NEWSLETTER
PAGE
VOLUME
NUMBER
APRIL
MALARIA
AMONG
US
EMBASSY
PERSONNEL
KAMPALA
UGANDA
SOURCE
MMWR
DATE
APR
THE
TREATMENT
AND
PREVENTION
OF
MALARIA
IN
AFRICA
HAS
BECOME
A
CHALLENGING
AND
COMPLEX
PROBLEM
BECAUSE
OF
INCREASING
DRUG
RESISTANCE
ALTHOUGH
THE
RISK
OF
ACQUIRING
MALARIA
FOR
US
CITIZENS
AND
THEIR
DEPENDENTS
STATIONED
OVERSEAS
GENERALLY
HAS
BEEN
LOW
THIS
RISK
VARIES
SUBSTANTIALLY
AND
UNPREDICTABLY
DURING
MAY
THE
OFFICE
OF
MEDICAL
SERVICES
DEPARTMENT
OF
STATE
OMSDOS
AND
CDC
WERE
NOTIFIED
OF
AN
INCREASED
NUMBER
OF
MALARIA
CASES
AMONG
OFFICIAL
US
PERSONNEL
STATIONED
IN
KAMPALA
UGANDA
A
REVIEW
OF
THE
HEALTH
RECORDS
FROM
THE
EMBASSY
HEALTH
UNIT
EHU
IN
KAMPALA
INDICATED
THAT
CASES
OF
MALARIA
WERE
DIAGNOSED
IN
OFFICIAL
PERSONNEL
FROM
MARCH
THROUGH
JUNE
COMPARED
WITH
TWO
CASES
DURING
THE
SAME
PERIOD
IN
EHU
OMSDOS
AND
CDC
CONDUCTED
AN
INVESTIGATION
TO
CONFIRM
ALL
REPORTED
MALARIA
CASES
AND
IDENTIFY
POTENTIAL
RISK
FACTORS
FOR
MALARIA
AMONG
US
EMBASSY
PERSONNEL
THIS
REPORT
SUMMARIZES
THE
RESULTS
OF
THE
INVESTIGATION
MALARIA
BLOOD
SMEARS
FROM
OF
THE
REPORTED
CASEPATIENTS
WERE
AVAILABLE
FOR
REVIEW
BY
OMSDOS
AND
CDC
A
CASE
OF
MALARIA
WAS
CONFIRMED
IF
THE
SLIDE
WAS
POSITIVE
FOR
PLASMODIUM
SP
OF
THE
PERSONS
WERE
SLIDE
CONFIRMED
AS
HAVING
MALARIA
A
QUESTIONNAIRE
WAS
DISTRIBUTED
TO
ALL
PERSONS
SERVED
BY
THE
EHU
TO
OBTAIN
INFORMATION
ABOUT
RESIDENCE
ACTIVITIES
USE
OF
MALARIA
CHEMOPROPHYLAXIS
AND
USE
OF
PERSONAL
PROTECTION
MEASURES
IE
USING
BEDNETS
AND
INSECT
REPELLENTS
HAVING
WINDOW
AND
DOOR
SCREENS
AND
WEARING
LONG
SLEEVES
AND
PANTS
IN
THE
EVENING
OF
THE
PERSONS
ELIGIBLE
FOR
THE
SURVEY
RESPONDED
RISK
FOR
MALARIA
WAS
NOT
ASSOCIATED
WITH
SEX
OR
LOCATION
OF
RESIDENCE
IN
KAMPALA
ALTHOUGH
THE
RISK
FOR
MALARIA
WAS
HIGHER
AMONG
CHILDREN
AGED
LESS
THAN
OR
EQUAL
TO
YEARS
THAN
AMONG
PERSONS
GREATER
THAN
YEARS
THIS
DIFFERENCE
WAS
NOT
SIGNIFICANT
RELATIVE
RISK
CONFIDENCE
INTERVAL
EIGHTYTWO
PERCENT
OF
THE
CASES
OCCURRED
AMONG
PERSONS
WHO
HAD
BEEN
LIVING
IN
KAMPALA
FOR
YEARS
COMPARED
WITH
THOSE
LIVING
THERE
LESS
THAN
YEAR
TRAVEL
OUTSIDE
OF
THE
KAMPALA
AREA
TO
MORE
RURAL
SETTINGS
WAS
NOT
ASSOCIATED
WITH
INCREASED
RISK
FOR
MALARIA
FOUR
MALARIA
CHEMOPROPHYLAXIS
REGIMENS
WERE
USED
BY
PERSONS
WHO
PARTICIPATED
IN
THE
SURVEY
MEFLOQUINE
CHLOROQUINE
AND
PROGUANIL
CHLOROQUINE
ALONE
AND
PROGUANIL
ALONE
IN
ADDITION
PERSONS
WHO
RESPONDED
WERE
NOT
USING
ANY
MALARIA
CHEMOPROPHYLAXIS
THE
RISK
FOR
MALARIA
WAS
SIGNIFICANTLY
LOWER
AMONG
PERSONS
USING
EITHER
MEFLOQUINE
OR
CHLOROQUINE
AND
PROGUANIL
THAN
AMONG
PERSONS
USING
THE
OTHER
REGIMENS
OR
NO
PROPHYLAXIS
TWELVE
PERSONS
NOT
USING
PROPHYLAXIS
REPORTED
SIDE
EFFECTS
OR
FEAR
OF
POSSIBLE
SIDE
EFFECTS
AS
A
REASON
THE
RISK
FOR
MALARIA
WAS
LOWER
AMONG
PERSONS
WHO
REPORTED
USING
BEDNETS
HICNET
MEDICAL
NEWSLETTER
PAGE
VOLUME
NUMBER
APRIL
ALL
OR
MOST
OF
THE
TIME
THAN
AMONG
PERSONS
WHO
SOMETIMES
OR
RARELY
USED
BEDNETS
THE
RISK
FOR
MALARIA
WAS
ALSO
LOWER
AMONG
PERSONS
WHO
CONSISTENTLY
USED
INSECT
REPELLENT
IN
THE
EVENING
COMPARED
WITH
THOSE
WHO
RARELY
USED
REPELLENT
UPPER
CONFIDENCE
RISK
FOR
MALARIA
WAS
NOT
ASSOCIATED
WITH
FAILURE
TO
HAVE
WINDOW
OR
DOOR
SCREENS
OR
WEAR
LONG
SLEEVES
OR
PANTS
IN
THE
EVENING
AS
A
RESULT
OF
THIS
INVESTIGATION
EHU
STAFF
REVIEWED
WITH
ALL
PERSONNEL
THE
NEED
TO
USE
AND
COMPLY
WITH
THE
RECOMMENDED
MALARIA
CHEMOPROPHYLAXIS
REGIMENS
EHU
STAFF
ALSO
EMPHASIZED
THE
NEED
TO
USE
PERSONAL
PROTECTION
MEASURES
AND
MADE
PLANS
TO
OBTAIN
INSECTICIDEIMPREGNATED
BEDNETS
AND
TO
PROVIDE
WINDOW
AND
DOOR
SCREENS
FOR
ALL
PERSONNEL
REPORTED
BY
US
EMBASSY
HEALTH
UNIT
KAMPALA
UGANDA
OFFICE
OF
MEDICAL
SVCS
DEPT
OF
STATE
WASHINGTON
DC
MALARIA
BR
DIV
OF
PARASITIC
DISEASES
NATIONAL
CENTER
FOR
INFECTIOUS
DISEASES
CDC
EDITORIAL
NOTE
IN
UGANDA
THE
INCREASE
IN
MALARIA
AMONG
US
PERSONNEL
WAS
ATTRIBUTED
TO
POOR
ADHERENCE
TO
BOTH
RECOMMENDED
MALARIA
CHEMOPROPHYLAXIS
REGIMENS
AND
USE
OF
PERSONAL
PROTECTION
MEASURES
DURING
A
PERIOD
OF
INCREASED
MALARIA
TRANSMISSION
AND
INTENSIFIED
CHLOROQUINE
RESISTANCE
IN
SUBSAHARAN
AFRICA
THE
FINDINGS
IN
THIS
REPORT
UNDERSCORE
THE
NEED
TO
PROVIDE
INITIAL
AND
CONTINUED
COUNSELING
REGARDING
MALARIA
PREVENTION
FOR
PERSONS
LIVING
ABROAD
IN
MALARIAENDEMIC
AREAS
PREVENTIVE
MEASURES
THAT
ARE
ALSO
IMPORTANT
FOR
SHORTTERM
TRAVELERS
TO
SUCH
AREAS
MEFLOQUINE
IS
AN
EFFECTIVE
PROPHYLAXIS
REGIMEN
IN
AFRICA
AND
IN
MOST
OTHER
AREAS
WITH
CHLOROQUINERESISTANT
P
FALCIPARUM
HOWEVER
IN
SOME
AREAS
EG
THAILAND
RESISTANCE
TO
MEFLOQUINE
MAY
LIMIT
ITS
EFFECTIVENESS
IN
AFRICA
THE
EFFICACY
OF
MEFLOQUINE
COMPARED
WITH
CHLOROQUINE
ALONE
IN
PREVENTING
INFECTION
WITH
P
FALCIPARUM
IS
MEFLOQUINE
IS
SAFE
AND
WELL
TOLERATED
WHEN
GIVEN
AT
MG
PER
WEEK
OVER
A
PERIOD
THE
RISK
FOR
SERIOUS
ADVERSE
REACTIONS
POSSIBLY
ASSOCIATED
WITH
MEFLOQUINE
PROPHYLAXIS
EG
PSYCHOSIS
AND
CONVULSIONS
IS
LOW
IE
EPISODES
PER
USERS
WHILE
THE
RISK
FOR
LESS
SEVERE
ADVERSE
REACTIONS
EG
DIZZINESS
GASTROINTESTINAL
COMPLAINTS
AND
SLEEP
DISTURBANCES
IS
SIMILAR
TO
THAT
FOR
OTHER
ANTIMALARIAL
CHEMOPROPHYLACTICS
DOXYCYCLINE
HAS
SIMILAR
PROPHYLACTIC
EFFICACY
TO
MEFLOQUINE
BUT
THE
NEED
FOR
DAILY
DOSING
MAY
REDUCE
COMPLIANCE
WITH
AND
EFFECTIVENESS
OF
THIS
REGIMEN
CHLOROQUINE
ALONE
IS
NOT
EFFECTIVE
AS
PROPHYLAXIS
IN
AREAS
OF
INTENSE
CHLOROQUINE
RESISTANCE
EG
SOUTHEAST
ASIA
AND
AFRICA
IN
AFRICA
FOR
PERSONS
WHO
CANNOT
TAKE
MEFLOQUINE
OR
DOXYCYCLINE
CHLOROQUINE
AND
PROGUANIL
IS
AN
ALTERNATIVE
ALTHOUGH
LESS
EFFECTIVE
REGIMEN
CHLOROQUINE
SHOULD
BE
USED
FOR
MALARIA
PREVENTION
IN
AREAS
ONLY
WHERE
CHLOROQUINERESISTANT
P
FALCIPARUM
HAS
NOT
BEEN
REPORTED
COUNTRYSPECIFIC
RECOMMENDATIONS
FOR
PREVENTING
MALARIA
AND
INFORMATION
HICNET
MEDICAL
NEWSLETTER
PAGE
VOLUME
NUMBER
APRIL
ON
THE
DOSAGE
AND
PRECAUTIONS
FOR
MALARIA
CHEMOPROPHYLAXIS
REGIMENS
ARE
AVAILABLE
FROM
HEALTH
INFORMATION
FOR
INTERNATIONAL
TRAVEL
IE
YELLOW
BOOK
OR
HOURS
A
DAY
BY
TELEPHONE
OR
FAX
REFERENCES
LOBEL
HO
MIANI
M
ENG
T
ET
AL
LONGTERM
MALARIA
PROPHYLAXIS
WITH
WEEKLY
MEFLOQUINE
IN
PEACE
CORPS
VOLUNTEERS
AN
EFFECTIVE
AND
WELL
TOLERATED
REGIMEN
LANCET
WORLD
HEALTH
ORGANIZATION
REVIEW
OF
CENTRAL
NERVOUS
SYSTEM
ADVERSE
EVENTS
RELATED
TO
THE
ANTIMALARIAL
DRUG
MEFLOQUINE
GENEVA
WORLD
HEALTH
ORGANIZATION
PUBLICATION
NO
PANG
L
LIMSOMWONG
N
SINGHARAJ
P
PROPHYLACTIC
TREATMENT
OF
VIVAX
AND
FALCIPARUM
MALARIA
WITH
LOWDOSE
DOXYCYCLINE
J
INFECT
DIS
PANG
L
LIMSOMWONG
N
BOUDREAU
EF
SINGHARAJ
P
DOXYCYCLINE
PROPHYLAXIS
FOR
FALCIPARUM
MALARIA
LANCET
CDC
HEALTH
INFORMATION
FOR
INTERNATIONAL
TRAVEL
ATLANTA
US
DEPARTMENT
OF
HEALTH
AND
HUMAN
SERVICES
PUBLIC
HEALTH
SERVICE
DHHS
PUBLICATION
NO
HICNET
MEDICAL
NEWSLETTER
PAGE
VOLUME
NUMBER
APRIL
FDA
APPROVAL
OF
USE
OF
A
NEW
HAEMOPHILUS
B
CONJUGATE
VACCINE
AND
A
COMBINED
DIPHTHERIATETANUSPERTUSSIS
AND
HAEMOPHILUS
B
CONJUGATE
VACCINE
FOR
INFANTS
AND
CHILDREN
SOURCE
MMWR
DATE
APR
HAEMOPHILUS
INFLUENZAE
TYPE
B
HIB
CONJUGATE
VACCINES
HAVE
BEEN
RECOMMENDED
FOR
USE
IN
INFANTS
SINCE
AND
THEIR
ROUTINE
USE
IN
INFANT
VACCINATION
HAS
CONTRIBUTED
TO
THE
SUBSTANTIAL
DECLINE
IN
THE
INCIDENCE
OF
HIB
DISEASE
IN
THE
UNITED
STATES
VACCINES
AGAINST
DIPHTHERIA
TETANUS
AND
PERTUSSIS
DURING
INFANCY
AND
CHILDHOOD
HAVE
BEEN
ADMINISTERED
ROUTINELY
IN
THE
UNITED
STATES
SINCE
THE
LATE
AND
HAS
BEEN
ASSOCIATED
WITH
A
GREATER
THAN
REDUCTION
IN
MORBIDITY
AND
MORTALITY
ASSOCIATED
WITH
INFECTION
BY
THESE
ORGANISMS
BECAUSE
OF
THE
INCREASING
NUMBER
OF
VACCINES
NOW
ROUTINELY
RECOMMENDED
FOR
INFANTS
A
HIGH
PRIORITY
IS
THE
DEVELOPMENT
OF
COMBINED
VACCINES
THAT
ALLOW
SIMULTANEOUS
ADMINISTRATION
WITH
FEWER
SEPARATE
INJECTIONS
THE
FOOD
AND
DRUG
ADMINISTRATION
FDA
RECENTLY
LICENSED
TWO
NEW
PRODUCTS
FOR
VACCINATING
CHILDREN
AGAINST
THESE
DISEASES
THE
HAEMOPHILUS
B
CONJUGATE
VACCINE
TETANUS
TOXOID
CONJUGATE
ACTHIB
TRADEMARK
FOR
VACCINATION
AGAINST
HIB
DISEASE
ONLY
AND
A
COMBINED
DIPHTHERIA
AND
TETANUS
TOXOIDS
AND
WHOLECELL
PERTUSSIS
VACCINE
DTP
AND
HIB
CONJUGATE
VACCINE
TETRAMUNE
TRADEMARK
A
COMBINATION
OF
VACCINES
FORMULATED
FOR
USE
IN
VACCINATING
CHILDREN
AGAINST
DIPHTHERIA
TETANUS
PERTUSSIS
AND
HIB
DISEASE
ACTHIB
TRADEMARK
ON
MARCH
THE
FDA
APPROVED
A
NEW
HAEMOPHILUS
B
CONJUGATE
VACCINE
POLYRIBOSYLRIBITOL
PHOSPHATETETANUS
TOXOID
CONJUGATE
PRPT
MANUFACTURED
BY
PASTEUR
MERIEUX
SERUM
ET
VACCINS
AND
DISTRIBUTED
AS
ACTHIB
TRADEMARK
BY
CONNAUGHT
LABORATORIES
INC
SWIFTWATER
PENNSYLVANIA
THIS
VACCINE
HAS
BEEN
LICENSED
FOR
USE
IN
INFANTS
IN
A
THREEDOSE
PRIMARY
VACCINATION
SERIES
ADMINISTERED
AT
AGES
AND
MONTHS
PREVIOUSLY
UNVACCINATED
INFANTS
MONTHS
OF
AGE
SHOULD
RECEIVE
TWO
DOSES
MONTHS
APART
PREVIOUSLY
UNVACCINATED
CHILDREN
MONTHS
OF
AGE
SHOULD
RECEIVE
ONE
DOSE
A
BOOSTER
DOSE
ADMINISTERED
AT
MONTHS
OF
AGE
IS
RECOMMENDED
FOR
ALL
CHILDREN
PREVIOUSLY
UNVACCINATED
CHILDREN
MONTHS
OF
AGE
SHOULD
RECEIVE
A
SINGLE
DOSE
AND
DO
NOT
REQUIRE
A
BOOSTER
MORE
THAN
OF
INFANTS
RECEIVING
A
PRIMARY
VACCINATION
SERIES
OF
ACTHIB
TRADEMARK
CONSECUTIVE
DOSES
AT
AND
MONTHS
OF
AGE
DEVELOP
A
GEOMETRIC
MEAN
TITER
OF
ANTIHAEMOPHILUS
B
POLYSACCHARIDE
ANTIBODY
GREATER
THAN
UGML
THIS
RESPONSE
IS
SIMILAR
TO
THAT
OF
INFANTS
WHO
RECEIVE
RECOMMENDED
SERIES
OF
PREVIOUSLY
LICENSED
HAEMOPHILUS
B
CONJUGATE
VACCINES
FOR
WHICH
EFFICACY
HAS
BEEN
DEMONSTRATED
IN
PROSPECTIVE
TRIALS
TWO
US
EFFICACY
TRIALS
OF
PRPT
WERE
TERMINATED
EARLY
BECAUSE
OF
THE
CONCOMITANT
LICENSURE
OF
OTHER
HAEMOPHILUS
B
CONJUGATE
VACCINES
HICNET
MEDICAL
NEWSLETTER
PAGE
VOLUME
NUMBER
APRIL
FOR
USE
IN
INFANTS
IN
THESE
STUDIES
NO
CASES
OF
INVASIVE
HIB
DISEASE
WERE
DETECTED
IN
APPROXIMATELY
INFANTS
VACCINATED
WITH
PRPT
THESE
AND
OTHER
STUDIES
SUGGEST
THAT
THE
EFFICACY
OF
PRPT
VACCINE
WILL
BE
SIMILAR
TO
THAT
OF
THE
OTHER
LICENSED
HIB
VACCINES
TETRAMUNE
TRADEMARK
ON
MARCH
THE
FDA
APPROVED
A
COMBINED
DIPHTHERIA
AND
TETANUS
TOXOIDS
AND
WHOLECELL
PERTUSSIS
VACCINE
DTP
AND
HAEMOPHILUS
B
CONJUGATE
VACCINE
TETRAMUNE
TRADEMARK
AVAILABLE
FROM
LEDERLEPRAXIS
BIOLOGICALS
PEARL
RIVER
NEW
YORK
COMBINES
TWO
PREVIOUSLY
LICENSED
PRODUCTS
DTP
TRIIMMUNOL
REGISTERED
MANUFACTURED
BY
LEDERLE
LABORATORIES
PEARL
RIVER
NEW
YORK
AND
HAEMOPHILUS
B
CONJUGATE
VACCINE
HIBTITER
REGISTERED
MANUFACTURED
BY
PRAXIS
BIOLOGICS
INC
ROCHESTER
NEW
YORK
THIS
VACCINE
HAS
BEEN
LICENSED
FOR
USE
IN
CHILDREN
AGED
YEARS
FOR
PROTECTION
AGAINST
DIPHTHERIA
TETANUS
PERTUSSIS
AND
HIB
DISEASE
WHEN
INDICATIONS
FOR
VACCINATION
WITH
DTP
VACCINE
AND
HAEMOPHILUS
B
CONJUGATE
VACCINE
COINCIDE
BASED
ON
DEMONSTRATION
OF
CO
MPARABLE
OR
HIGHER
ANTIBODY
RESPONSES
TO
EACH
OF
THE
COMPONENTS
OF
THE
TWO
VACCINES
TETRAMUNE
TRADEMARK
IS
EXPECTED
TO
PROVIDE
PROTECTION
AGAINST
HIB
AS
WELL
AS
DIPHTHERIA
TETANUS
AND
PERTUSSIS
EQUIVALENT
TO
THAT
OF
ALREADY
LICENSED
FORMULATIONS
OF
OTHER
DTP
AND
HAEMOPHILUS
B
VACCINES
THE
ADVISORY
COMMITTEE
FOR
IMMUNIZATION
PRACTICES
ACIP
RECOMMENDS
THAT
ALL
INFANTS
RECEIVE
A
PRIMARY
SERIES
OF
ONE
OF
THE
LICENSED
HAEMOPHILUS
B
CONJUGATE
VACCINES
BEGINNING
AT
MONTHS
OF
AGE
AND
A
BOOSTER
DOSE
AT
AGE
MONTHS
THE
ACIP
ALSO
RECOMMENDS
THAT
ALL
INFANTS
RECEIVE
A
FOURDOSE
PRIMARY
SERIES
OF
DIPHTHERIA
AND
TETANUS
TOXOIDS
AND
PERTUSSIS
VACCINE
AT
AND
MONTHS
OF
AGE
AND
A
BOOSTER
DOSE
AT
YEARS
A
COMPLETE
STATEMENT
REGARDING
RECOMMENDATIONS
FOR
USE
OF
ACTHIB
TRADEMARK
AND
TETRAMUNE
TRADEMARK
IS
BEING
DEVELOPED
REPORTED
BY
OFFICE
OF
VACCINES
RESEARCH
AND
REVIEW
CENTER
FOR
BIOLOGICS
EVALUATION
AND
RESEARCH
FOOD
AND
DRUG
ADMINISTRATION
DIV
OF
IMMUNIZATION
NATIONAL
CENTER
FOR
PREVENTION
SVCS
MENINGITIS
AND
SPECIAL
PATHOGENS
BR
DIV
OF
BACTERIAL
AND
MYCOTIC
DISEASES
NATIONAL
CENTER
FOR
INFECTIOUS
DISEASES
CDC
REFERENCES
ADAMS
WG
DEAVER
KA
COCHI
SL
ET
AL
DECLINE
OF
CHILDHOOD
HAEMOPHILUS
INFLUENZAE
TYPE
B
HIB
DISEASE
IN
THE
HIB
VACCINE
ERA
JAMA
BROADHURST
LE
ERICKSON
RL
KELLEY
PW
DECREASE
IN
INVASIVE
HAEMOPHILUS
INFLUENZAE
DISEASE
IN
US
ARMY
CHILDREN
THROUGH
JAMA
MURPHY
TV
WHITE
KE
PASTOR
P
ET
AL
DECLINING
INCIDENCE
OF
HAEMOPHILUS
INFLUENZAE
TYPE
B
DISEASE
SINCE
INTRODUCTION
OF
VACCINATION
JAMA
HICNET
MEDICAL
NEWSLETTER
PAGE
VOLUME
NUMBER
APRIL
FRITZELL
B
PLOTKIN
S
EFFICACY
AND
SAFETY
OF
A
HAEMOPHILUS
INFLUENZAE
TYPE
B
CAPSULAR
POLYSACCHARIDETETANUS
PROTEIN
CONJUGATE
VACCINE
J
PEDIATR
ACIP
HAEMOPHILUS
B
CONJUGATE
VACCINES
FOR
PREVENTION
OF
HAEMOPHILUS
INFLUENZAE
TYPE
B
DISEASE
AMONG
INFANTS
AND
CHILDREN
TWO
MONTHS
OF
AGE
AND
OLDER
RECOMMENDATIONS
OF
THE
IMMUNIZATION
PRACTICES
ADVISORY
COMMITTEE
ACIP
MMWR
ACIP
DIPHTHERIA
TETANUS
AND
PERTUSSIS
RECOMMENDATIONS
FOR
VACCINE
USE
AND
OTHER
PREVENTIVE
MEASURES
RECOMMENDATIONS
OF
THE
IMMUNIZATION
PRACTICES
ADVISORY
COMMITTEE
ACIP
MMWR
ACIP
PERTUSSIS
VACCINATION
ACELLULAR
PERTUSSIS
VACCINE
FOR
REINFORCING
AND
BOOSTER
USE
SUPPLEMENTARY
ACIP
STATEMENT
RECOMMENDATIONS
OF
THE
IMMUNIZATION
PRACTICES
ADVISORY
COMMITTEE
ACIP
MMWR
ACIP
PERTUSSIS
VACCINATION
ACELLULAR
PERTUSSIS
VACCINE
FOR
THE
FOURTH
AND
FIFTH
DOSES
OF
THE
DTP
SERIES
UPDATE
TO
SUPPLEMENTARY
ACIP
STATEMENT
RECOMMENDATIONS
OF
THE
IMMUNIZATION
PRACTICES
ADVISORY
COMMITTEE
ACIP
MMWR
USE
OF
TRADE
NAMES
AND
COMMERCIAL
SOURCES
IS
FOR
IDENTIFICATION
ONLY
AND
DOES
NOT
IMPLY
ENDORSEMENT
BY
THE
PUBLIC
HEALTH
SERVICE
OR
THE
US
DEPARTMENT
OF
HEALTH
AND
HUMAN
SERVICES
HICNET
MEDICAL
NEWSLETTER
PAGE
VOLUME
NUMBER
APRIL
DENTAL
NEWS
INTERNATIONAL
WORKSHOP
EXPLORES
ORAL
MANIFESTATIONS
OF
HIV
INFECTION
NIDR
RESEARCH
DIGEST
WRITTEN
BY
JODY
DOVE
MARCH
NATIONAL
INSTITUTE
OF
DENTAL
RESEARCH
AT
THE
SECOND
INTERNATIONAL
WORKSHOP
ON
THE
ORAL
MANIFESTATIONS
OF
HIV
INFECTION
HELD
JANUARY
IN
SAN
FRANCISCO
PARTICIPANTS
EXPLORED
ISSUES
RELATED
TO
THE
EPIDEMIOLOGY
BASIC
MOLECULAR
VIROLOGY
MUCOSAL
IMMUNOLOGY
AND
ORAL
CLINICAL
PRESENTATIONS
OF
HIV
INFECTION
THE
WORKSHOP
WAS
ORGANIZED
BY
DR
JOHN
GREENSPAN
AND
DR
DEBORAH
GREENSPAN
OF
THE
DEPARTMENT
OF
STOMATOLOGY
SCHOOL
OF
DENTISTRY
UNIVERSITY
OF
CALIFORNIA
SAN
FRANCISCO
AN
INTERNATIONAL
STEERING
COMMITTEE
AND
SCIENTIFIC
PROGRAM
COMMITTEE
PROVIDED
GUIDANCE
THE
CONFERENCE
DREW
MORE
THAN
SCIENTISTS
FROM
COUNTRIES
INCLUDING
ASIA
AFRICA
EUROPE
CENTRAL
AMERICA
SOUTH
AMERICA
AS
WELL
AS
THE
UNITED
STATES
AND
CANADA
SUPPORT
TOR
THE
WORKSHOP
WAS
PROVIDED
BY
THE
NATIONAL
INSTITUTE
OF
DENTAL
RESEARCH
THE
NATIONAL
CANCER
INSTITUTE
THE
NATIONAL
INSTITUTE
OF
ALLERGY
AND
INFECTIOUS
DISEASES
THE
NIH
OFFICE
OF
AIDS
RESEARCH
AND
THE
PROCTER
AND
GAMBLE
COMPANY
AMONG
THE
TOPICS
DISCUSSED
WERE
THE
EPIDEMIOLOGY
OF
HIV
LESIONS
ETHICS
PROFESSIONAL
RESPONSIBILITY
AND
PUBLIC
POLICY
OCCUPATIONAL
ISSUES
PROVISION
OF
ORAL
CARE
TO
THE
HIVPOSITIVE
POPULATION
SALIVARY
HIV
TRANSMISSION
AND
MUCOSAL
IMMUNITY
OPPORTUNISTIC
INFECTIONS
PEDIATRIC
HIV
INFECTION
AND
WOMENS
ISSUES
RECOMMENDATIONS
RECOMMENDATIONS
EMERGED
FROM
THE
WORKSHOP
TO
DEFINE
THE
ASSOCIATION
BETWEEN
THE
APPEARANCE
OF
ORAL
LESIONS
AND
RATE
OF
PROGRESSION
OF
HIV
TO
ESTABLISH
A
UNIVERSAL
TERMINOLOGY
FOR
HIVASSOCIATED
ORAL
LESIONS
TO
LOOK
FOR
MORE
EFFECTIVE
TREATMENTS
FOR
ORAL
MANIFESTATIONS
TO
EXPAND
MOLECULAR
BIOLOGY
STUDIES
TO
UNDERSTAND
THE
RELATIONSHIP
BETWEEN
HIV
INFECTION
AND
COMMON
ORAL
LESIONS
AND
TO
STUDY
THE
EFFECTS
OF
HIV
THERAPY
ON
ORAL
LESIONS
EPIDEMIOLOGY
SINCE
THE
FIRST
INTERNATIONAL
WORKSHOP
ON
ORAL
MANIFESTATIONS
OF
HIV
INFECTION
WAS
CONVENED
FIVE
YEARS
AGO
THE
EPIDEMIOLOGY
OF
HIV
INFECTION
HAS
HICNET
MEDICAL
NEWSLETTER
PAGE
VOLUME
NUMBER
APRIL
RADICALLY
CHANGED
IN
HIV
INFECTION
WAS
DETECTED
AND
REPORTED
LARGELY
IN
HOMOSEXUAL
AND
BISEXUAL
MALES
INTRAVENOUS
DRUG
USERS
AND
HEMOPHILIACS
TODAY
MORE
HIV
INFECTION
IS
SEEN
IN
HETEROSEXUAL
MALES
AND
FEMALES
AND
IN
CHILDREN
AND
ADOLESCENTS
WHILE
THE
PREDOMINANT
IMPACT
OF
HIV
INFECTION
HAS
BEEN
FELT
IN
AFRICA
A
MAJOR
INCREASE
IN
INFECTION
RATE
IS
BEING
SEEN
IN
SOUTHEAST
ASIA
AS
WELL
FIVE
HUNDRED
THOUSAND
CASES
HAVE
BEEN
REPORTED
TO
DATE
IN
THIS
REGION
AND
MORE
ARE
APPEARING
ALL
THE
TIME
RESEARCHERS
ARE
CONTINUING
TO
DOCUMENT
THE
EPIDEMIOLOGY
OF
ORAL
LESIONS
SUCH
AS
HAIRY
LEUKOPLAKIA
AND
CANDIDIASIS
THEY
ALSO
ARE
BEGINNING
TO
EXPLORE
THE
RELATIONSHIPS
BETWEEN
SPECIFIC
ORAL
LESIONS
AND
HIV
DISEASE
PROGRESSION
AND
PROGNOSIS
SOCIALPOLITICAL
ISSUES
DISCUSSION
ON
THE
SOCIAL
AND
POLITICAL
IMPLICATIONS
OF
HIV
INFECTION
FOCUSED
ON
CHANGING
THE
PUBLICS
ATTITUDE
THAT
AIDS
IS
RETRIBUTION
FOR
INDISCRIMINATE
SEXUAL
BEHAVIOR
AND
DRUG
USE
SPEAKERS
ALSO
ADDRESSED
HEALTH
CARE
DELIVERY
FOR
HIVINFECTED
PATIENTS
AND
THE
NEED
TO
EDUCATE
THE
PUBLIC
ABOUT
WHAT
AIDS
IS
AND
HOW
IT
IS
ACQUIRED
SALIVA
AND
SALIVARY
GLANDS
CONFERENCE
SPEAKERS
DESCRIBED
TRANSMISSION
ISSUES
AND
THE
HIVINHIBITORY
ACTIVITY
OF
SALIVA
THE
STRENGTH
OF
WHICH
VARIES
AMONG
THE
DIFFERENT
SALIVARY
SECRETIONS
WHOLE
SALIVA
HAS
A
GREATER
INHIBITORY
EFFECT
THAN
SUBMANDIBULAR
SECRETIONS
WHICH
IN
TURN
HAVE
A
GREATER
INHIBITORY
EFFECT
THAN
PAROTID
SECRETIONS
RESEARCH
HAS
SHOWN
THAT
AT
LEAST
TWO
MECHANISMS
ARE
RESPONSIBLE
FOR
SALIVARY
INHIBITORY
ACTIVITY
THEY
ATTRIBUTED
THE
HIVINHIBITORY
EFFECT
OF
SALIVA
TO
THE
AGGREGATIONAGGLUTINATION
OF
HIV
BY
SALIVA
WHICH
MAY
BOTH
PROMOTE
CLEARANCE
OF
VIRUS
AND
PREVENT
IT
REACHING
A
TARGET
CELL
AND
DIRECT
EFFECTS
ON
THE
VIRUS
OR
TARGET
CELLS
OTHER
TOPICS
DISCUSSED
WERE
THE
MANIFESTATION
OF
SALIVARY
GLAND
DISEASE
IN
HIVINFECTED
PERSONS
AND
CURRENT
RESEARCH
ON
ORAL
MUCOSAL
IMMUNITY
PEDIATRIC
ISSUES
PEDIATRIC
AIDS
RECENTLY
HAS
EMERGED
AS
AN
AREA
OF
INTENSE
INTEREST
WITH
EARLY
AND
ACCURATE
DIAGNOSIS
AND
PROPER
TREATMENT
THE
LIFE
EXPECTANCY
OF
HIV
INFECTED
CHILDREN
HAS
TRIPLED
THE
PREVENTION
OF
TRANSMISSION
OF
HIV
FROM
MOTHER
TO
CHILD
MAY
BE
POSSIBLE
IN
MANY
CASES
PARTICULARLY
IF
THE
MOTHERS
SEROSTATUS
IS
KNOWN
PRIOR
TO
GIVING
BIRTH
PERIODONTAL
AND
GINGIVAL
TISSUE
DISEASE
HICNET
MEDICAL
NEWSLETTER
PAGE
VOLUME
NUMBER
APRIL
ORAL
HEALTH
RESEARCHERS
CONTINUE
TO
EXPLORE
PERIODONTAL
DISEASES
AND
GINGIVITIS
FOUND
IN
INDIVIDUALS
WITH
HIV
INFECTION
RECOMMENDATIONS
MADE
AT
THE
WORKSHOP
INCLUDE
THE
STANDARDIZATION
OF
TERMINOLOGY
REFINEMENT
OF
DIAGNOSTIC
MARKERS
STANDARDIZATION
OF
STUDY
DESIGN
AND
PROPER
CONSIDERATION
OF
CONFOUNDING
VARIABLES
RESULTING
FROM
PERIODONTAL
THERAPY
OCCUPATIONAL
AND
TREATMENT
ISSUES
OCCUPATIONAL
ISSUES
SURROUNDING
THE
TREATMENT
OF
HIVINFECTED
INDIVIDUALS
AND
TREATMENT
RENDERED
BY
HIVINFECTED
HEALTH
CARE
PROFESSIONALS
STILL
COMMAND
CONSIDERABLE
ATTENTION
FACTORS
UNDER
CONSIDERATION
INCLUDE
THE
COSTBENEFIT
OF
HIV
TESTING
PATIENTTOHEALTH
CARE
PROVIDER
TRANSMISSION
OF
HIV
INFECTION
AND
THE
REVERSE
AND
THE
USE
OF
MAINSTREAM
VERSUS
DEDICATED
FACILITIES
FOR
THE
TREATMENT
OF
HIVINFECTED
PATIENTS
CONFERENCE
PARTICIPANTS
ANTICIPATE
THAT
A
THIRD
INTERNATIONAL
WORKSHOP
ON
THE
ORAL
MANIFESTATIONS
OF
HIV
INFECTION
WILL
BE
HELD
IN
FIVE
YEARS
OR
LESS
PROCEEDINGS
FROM
THE
SECOND
WORKSHOP
WILL
BE
PUBLISHED
BY
THE
QUINTESSENCE
COMPANY
IN
LATE
END
OF
PART
INTERNET
DAVIDSTATCOM
FAX
BITNET
FIDONET
AMATEUR
PACKET
